ClinConnect ClinConnect Logo
Search / Trial NCT03008291

His Bundle Pacing in Bradycardia and Heart Failure

Launched by YONG-MEI CHA · Dec 30, 2016

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at different types of heart pacing treatments for patients with bradycardia (a slow heart rate) and heart failure. The study will involve participants who need a pacemaker or other devices to help manage their heart conditions. Researchers want to understand how two specific types of pacing, called His bundle pacing and left bundle area pacing, affect the way electrical signals move through the heart. This information could help improve treatment for patients with heart failure or heart rhythm problems.

To be eligible for this trial, participants should be between the ages of 65 and 74, and they may have heart failure or specific types of heart block or slow heart rates that require a pacemaker. During the study, participants can expect to have additional heart rhythm measurements taken while their pacemaker is being implanted. This trial is currently recruiting participants, and it's important to note that individuals under 18 years old or those who are pregnant cannot take part.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • HF Group
  • Clinically recommended to undergo PM, CRT-P, or CRT-D implantation or HIBP/LBAP (including HIBP/LBAP for patients with HF, for patients who have failed CRT implant or patients who are CRT non-responders)
  • Any QRS duration
  • LVEF ≤ 50%
  • AV Block/Bradycardia Group
  • Recommended to undergo dual chamber pacemaker implantation
  • Any AV block or Sinus Bradycardia
  • Exclusion Criteria:
  • Age \< 18 years
  • Pregnant

About Yong Mei Cha

Yong-Mei Cha is a dedicated clinical trial sponsor focused on advancing medical research and innovation through rigorous study design and execution. With a commitment to improving patient outcomes, the organization collaborates with healthcare professionals and researchers to conduct high-quality clinical trials across various therapeutic areas. Yong-Mei Cha emphasizes ethical practices and regulatory compliance, ensuring the safety and well-being of participants while striving to bring cutting-edge therapies to market. Through their expertise and passion for science, they aim to contribute significantly to the future of healthcare.

Locations

Rochester, Minnesota, United States

Patients applied

0 patients applied

Trial Officials

Yong-Mei Cha, M.D.

Principal Investigator

Mayo Clinic

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials